VIR · Vir Biotechnology, Inc. · Executive Compensation

$10.62 +0.04 (+0.38%) At close · Sep 11

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$1.80B

169.22M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marianne De Backer	M.Sc., Ph.D., MBA President, Chief Executive Officer and Director	$950,000	—	$2,296,800	$3,507,360	$1,002,750	$77,135	$7,834,045
Mark Eisner	M.D., M.P.H. Executive Vice President and Chief Medical Officer	$660,833	$375,000	$382,800	$584,560	$354,291	$14,000	$2,371,484
Jason O’Byrne	Executive Vice President and Chief Financial Officer	$534,417	$150,000	$382,800	$584,560	$286,051	$14,000	$1,951,828
Vanina de Verneuil	Executive Vice President, General Counsel and Corporate Secretary	$506,333	—	$334,950	$511,490	$329,648	$8,363	$1,690,784

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marianne De Backer	M.Sc., Ph.D., MBA Chief Executive Officer and Director	$920,833	$2,500,000	$1,769,250	$2,697,800	$1,021,200	$346,820	$9,255,903
Mark Eisner	M.D., M.P.H. Executive Vice President and Chief Medical Officer Ann (Aine) Hanly, Ph.D. Executive Vice President and Chief Technology Officer	$379,167	$375,000	$702,750	$1,075,095	$221,130	$3,123	$2,756,265
Jason O’Byrne	Executive Vice President and Chief Financial Officer	$130,492	$150,000	$648,000	$991,335	—	—	$1,919,827
Sung Lee	Former Executive Vice President and Chief Financial Officer	$184,527	$500,000	$404,400	$616,640	—	$33,990	$1,739,557
Vanina de Verneuil	Executive Vice President, General Counsel and Corporate Secretary	$486,667	$300,000	$227,475	$346,860	$296,352	$12,117	$1,669,471

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marianne De Backer	M.Sc., Ph.D., MBA Chief Executive Officer and Director	$675,000	$2,500,000	$13,419,803	$21,604,153	$855,360	$437,179	$39,491,495
Sung Lee	Former Executive Vice President and Chief Financial Officer	$402,865	—	$1,530,165	$2,472,231	$293,423	$149,690	$4,848,374
Jeffrey Calcagno	Executive Vice President and Chief Business Officer	$314,394	$400,000	$1,410,200	$2,269,432	$146,100	—	$4,540,126
Johanna Friedl-Naderer	Former Executive Vice President and Chief Operating Officer	$604,640	—	$1,620,600	$1,533,616	$273,843	$196,964	$4,395,064
Phillip Pang	M.D., Ph.D. Former Executive Vice President, Chief Medical Officer and Interim Head of Research Ann (Aine) Hanly, Ph.D. Executive Vice President and Chief Technology Officer	$527,000	—	$1,620,600	$1,533,616	$257,774	$13,200	$3,952,190
Steven Rice	Former Executive Vice President and Chief Administrative Officer	$281,265	—	$1,971,730	$1,007,805	—	—	$3,260,800
Howard Horn	Former Executive Vice President and Chief Financial Officer	$159,167	—	—	—	—	$442,133	$601,300
George Scangos	Former President and Chief Executive Officer	$325,000	—	—	—	—	$13,200	$338,200

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
George Scangos	Former President and Chief Executive Officer	$638,333	—	$2,489,730	$4,043,885	$295,750	$12,200	$7,479,898
Johanna Friedl-Naderer	Former Executive Vice President and Chief Operating Officer	$444,396	$1,100,000	$2,171,700	$907,412	$202,230	$86,416	$5,040,031
Phillip Pang	M.D., Ph.D. Former Executive Vice President, Chief Medical Officer and Interim Head of Research Ann (Aine) Hanly, Ph.D. Executive Vice President and Chief Technology Officer	$507,400	$125,000	$1,975,160	$1,578,694	$192,780	$12,200	$4,391,234
Howard Horn	Former Executive Vice President and Chief Financial Officer	$475,167	—	$1,031,800	$1,233,355	$150,413	$12,200	$2,902,935
Steven Rice	Former Executive Vice President and Chief Administrative Officer	$485,633	—	$589,600	$986,684	$184,464	—	$2,246,381

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
George Scangos	Former President and Chief Executive Officer	$575,000	—	$7,479,180	$12,129,858	$487,000	$11,600	$20,682,838
Phillip Pang	M.D., Ph.D. Former Executive Vice President, Chief Medical Officer and Interim Head of Research Ann (Aine) Hanly, Ph.D. Executive Vice President and Chief Technology Officer	$492,000	—	$2,156,160	$3,496,896	$276,864	$11,600	$6,433,520
Howard Horn	Former Executive Vice President and Chief Financial Officer	$461,250	—	$1,684,500	$2,731,950	$259,560	$11,600	$5,148,860
Steven Rice	Former Executive Vice President and Chief Administrative Officer	$471,500	—	$1,347,600	$2,185,560	$265,328	—	$4,269,988

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Steven Rice	Chief Administrative Officer Herbert (“Skip”) Virgin, M.D., Ph.D.	$441,667	—	—	$1,476,236	$256,956	—	$2,174,859
Howard Horn	Executive Vice President and Former Chief Financial Officer	$444,333	—	—	$960,186	$226,100	$11,400	$1,642,019
George Scangos	Former President and Chief Executive Officer	$544,583	—	—	—	$438,900	$11,400	$994,883
Michael Kamarck	Former Chief Technology Officer	$426,400	—	—	—	$266,000	$111,400	$803,800

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
George Scangos	President and Chief Executive Officer	$514,583	—	—	$3,158,780	$260,044	$11,200	$3,944,607
Howard Horn	Chief Financial Officer	$413,333	—	—	$1,614,687	$174,720	$11,200	$2,213,940

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
George Scangos	President and Chief Executive Officer	$512,019	—	—	—	$260,000	$11,000	$783,019

Executive changes

Person	Role	Change	Effective	Filed
Jason O'Byrne	Executive Vice President and Chief Financial Officer	Resigned	2026-08-03	2026-07-24
Timothy Coughlin	Chair of the Audit Committee	Appointed	2026-06-09	2026-06-10
Timothy Coughlin	Class III director	Appointed	2026-06-09	2026-06-10
Robert More, MBA	Chair of the Audit Committee	Appointed	2026-05-26	2026-05-28
Marianne De Backer, M.Sc., Ph.D., MBA	President	Appointed	2026-03-04	2026-03-04
Maninder Hora, Ph.D.	Executive Vice President and Chief Technical Operations Officer	Appointed	2025-02-27	2025-01-30
Jason O'Byrne	Executive Vice President and Chief Financial Officer	Appointed	2024-10-02	2024-09-10

Key facts CIK 1706431 CUSIP 92764N102 13F (30d) 78 filings 78 filers Visit website Investor relations